512 related articles for article (PubMed ID: 23274471)
21. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3.
Fontenot JD; Rudensky AY
Nat Immunol; 2005 Apr; 6(4):331-7. PubMed ID: 15785758
[TBL] [Abstract][Full Text] [Related]
22. Regulatory T cells in health and disease.
Rouse BT
J Intern Med; 2007 Jul; 262(1):78-95. PubMed ID: 17598816
[TBL] [Abstract][Full Text] [Related]
23. The Ets-1 transcription factor controls the development and function of natural regulatory T cells.
Mouly E; Chemin K; Nguyen HV; Chopin M; Mesnard L; Leite-de-Moraes M; Burlen-defranoux O; Bandeira A; Bories JC
J Exp Med; 2010 Sep; 207(10):2113-25. PubMed ID: 20855499
[TBL] [Abstract][Full Text] [Related]
24. Zebrafish FOXP3 is required for the maintenance of immune tolerance.
Sugimoto K; Hui SP; Sheng DZ; Nakayama M; Kikuchi K
Dev Comp Immunol; 2017 Aug; 73():156-162. PubMed ID: 28365195
[TBL] [Abstract][Full Text] [Related]
25. Current trends with FOXP3
Trinath J; Bayry J
Immunotherapy; 2019 Jun; 11(9):755-758. PubMed ID: 31094264
[No Abstract] [Full Text] [Related]
26. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
[TBL] [Abstract][Full Text] [Related]
27. The TGF-beta1/Foxp3 regulatory axis in immune self-tolerance: implications for health and disease.
Pyzik M; Piccirillo CA
Inflamm Allergy Drug Targets; 2006 Sep; 5(3):167-77. PubMed ID: 16918480
[TBL] [Abstract][Full Text] [Related]
28. Manipulating regulatory T cells: a promising strategy to treat autoimmunity.
Zhang D; Tu E; Kasagi S; Zanvit P; Chen Q; Chen W
Immunotherapy; 2015; 7(11):1201-11. PubMed ID: 26568117
[TBL] [Abstract][Full Text] [Related]
29. Human FOXP3
Wing JB; Tanaka A; Sakaguchi S
Immunity; 2019 Feb; 50(2):302-316. PubMed ID: 30784578
[TBL] [Abstract][Full Text] [Related]
30. Murine bone marrow chimeras developing autoimmunity after CTLA-4-blockade show an expansion of T regulatory cells with an activated cytokine profile.
De Somer L; Fevery S; Bullens DM; Rutgeerts O; Lenaerts C; Mathieu C; Boon L; Kasran A; Waer M; Billiau AD
Immunol Lett; 2010 Sep; 133(1):49-53. PubMed ID: 20600326
[TBL] [Abstract][Full Text] [Related]
31. Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.
Kumar P; Saini S; Khan S; Surendra Lele S; Prabhakar BS
Cell Immunol; 2019 May; 339():41-49. PubMed ID: 30482489
[TBL] [Abstract][Full Text] [Related]
32. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3.
Williams LM; Rudensky AY
Nat Immunol; 2007 Mar; 8(3):277-84. PubMed ID: 17220892
[TBL] [Abstract][Full Text] [Related]
33. Phenotypical and functional specialization of FOXP3+ regulatory T cells.
Campbell DJ; Koch MA
Nat Rev Immunol; 2011 Feb; 11(2):119-30. PubMed ID: 21267013
[TBL] [Abstract][Full Text] [Related]
34. The therapeutic potential of regulatory T cells for the treatment of autoimmune disease.
Bluestone JA; Trotta E; Xu D
Expert Opin Ther Targets; 2015; 19(8):1091-103. PubMed ID: 25881491
[TBL] [Abstract][Full Text] [Related]
35. [The role of regulatory T cells in the development of autoimmune process in multiple sclerosis].
Eliseeva DD; Zavalishin IA; Karaulov AV; Bykovskaia SN
Vestn Ross Akad Med Nauk; 2012; (3):68-74. PubMed ID: 22712278
[TBL] [Abstract][Full Text] [Related]
36. CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases.
Valencia X; Lipsky PE
Nat Clin Pract Rheumatol; 2007 Nov; 3(11):619-26. PubMed ID: 17968332
[TBL] [Abstract][Full Text] [Related]
37. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.
Peterson LB; Bell CJM; Howlett SK; Pekalski ML; Brady K; Hinton H; Sauter D; Todd JA; Umana P; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Klein C; Hosse RJ; Wicker LS
J Autoimmun; 2018 Dec; 95():1-14. PubMed ID: 30446251
[TBL] [Abstract][Full Text] [Related]
38. Functional defect in regulatory T cells in myasthenia gravis.
Thiruppathi M; Rowin J; Li Jiang Q; Sheng JR; Prabhakar BS; Meriggioli MN
Ann N Y Acad Sci; 2012 Dec; 1274(1):68-76. PubMed ID: 23252899
[TBL] [Abstract][Full Text] [Related]
39. Regulatory T cells: key players in tolerance and autoimmunity.
Chatila TA
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):265-72, vii. PubMed ID: 19328410
[TBL] [Abstract][Full Text] [Related]
40. Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns.
Miyara M; Sakaguchi S
Immunol Cell Biol; 2011 Mar; 89(3):346-51. PubMed ID: 21301480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
